| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |